Translate this page into:
Bilateral xanthogranulomatous pyelonephritis: Morphologically rotund, functionally lame!
Address for correspondence: Dr. Binit Sureka, Department of Radiology and Interventional Radiology, Institute of Liver and Biliary Sciences, New Delhi - 110 070, India. E-mail: binitsureka@hotmail.com
This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
This article was originally published by Medknow Publications & Media Pvt Ltd and was migrated to Scientific Scholar after the change of Publisher.
A 54-year-old diabetic male presented with pain in both flanks, recurrent fever and malaise for the past few months. Abdominal examination revealed tender vague masses in the both lumbar regions. Laboratory investigations showed hemoglobin of 7.7 g/dl and serum creatinine 2.8 mg/dl. Urinalysis demonstrated pus cells and Escherichia coli on culture. Ultrasound abdomen revealed bilateral enlarged hydronephrotic kidneys with papery-thin renal parenchyma. Noncontrast computed tomography (CT) revealed bilateral large staghorn calculi causing obstructive nephromegaly and hydronephrosis with low attenuation contents within the pelvicalyceal system. There was associated perinephric, juxtahilar and parapelvic fat proliferation causing bulging of bilateral renal fasciae, suggestive of bilateral diffuse xanthogranulomatous pyelonephritis (XGP) [Figure 1].
- (a) Computed tomography (CT) scout image showing bilateral staghorn calculi (arrows) with surrounding halo of lucency (b and c) Coronal MIP and axial noncontrast CT images showing bilateral staghorn calculi (arrows) resulting in nephromegaly and hydronephrosis with marked fat proliferation and adjacent inflammatory stranding
First described by Schlagenhaufer in 1916, XGP is a rare, serious, chronic inflammatory disorder characterized by destruction and replacement of renal parenchyma by lipid-laden macrophages (foam cells).[1] It is most commonly associated with Proteus or E. coli infection often seen in the setting of nephrolithiasis, diabetes and/or immunocompromised status. XGP constitutes <1% of chronic pyelonephritis and is thrice as common in women as in men. The disease can be either diffuse (85%) or focal (15%) in distribution. Most cases are unilateral and the affected kidney is usually nonfunctional. Bilateral diffuse involvement is rare and carries a grave prognosis. The typical imaging feature includes staghorn calculi, large kidneys with poor or absent renal function. Demonstrable macroscopic fat is infrequent on CT. Stage I disease remains confined to renal parenchyma; while in stage II and III, there is contiguous extension of the inflammatory process into the perinephric fat and adjacent retroperitoneal structures, respectively. Timely diagnosis and prompt therapy play a crucial role in limiting the morbidity and mortality. By the time XGP has become established, no conservative or medical therapies exist. Surgical nephrectomy is usually curative. The presence of inflammatory reaction in adjacent tissues often requires a large operative field and an anterolateral transperitoneal approach.[2]
Differential diagnoses are renal tuberculosis and renal abscesses in diffuse form; renal cell carcinoma and angiomyolipoma with minimal fat in focal form of XGP.
Source of Support: Nil
Conflict of Interest: None declared.
